1. Home
  2. EVO vs IAS Comparison

EVO vs IAS Comparison

Compare EVO & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • IAS
  • Stock Information
  • Founded
  • EVO 1993
  • IAS 2009
  • Country
  • EVO Germany
  • IAS United States
  • Employees
  • EVO N/A
  • IAS N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • IAS Computer Software: Programming Data Processing
  • Sector
  • EVO Health Care
  • IAS Technology
  • Exchange
  • EVO Nasdaq
  • IAS Nasdaq
  • Market Cap
  • EVO 1.5B
  • IAS 1.8B
  • IPO Year
  • EVO 2021
  • IAS 2021
  • Fundamental
  • Price
  • EVO $4.11
  • IAS $10.04
  • Analyst Decision
  • EVO Buy
  • IAS Buy
  • Analyst Count
  • EVO 2
  • IAS 11
  • Target Price
  • EVO $5.90
  • IAS $14.80
  • AVG Volume (30 Days)
  • EVO 184.0K
  • IAS 768.9K
  • Earning Date
  • EVO 11-06-2024
  • IAS 02-25-2025
  • Dividend Yield
  • EVO N/A
  • IAS N/A
  • EPS Growth
  • EVO N/A
  • IAS 258.32
  • EPS
  • EVO N/A
  • IAS 0.20
  • Revenue
  • EVO $866,665,179.00
  • IAS $511,358,000.00
  • Revenue This Year
  • EVO $3.89
  • IAS $11.97
  • Revenue Next Year
  • EVO $9.65
  • IAS $11.96
  • P/E Ratio
  • EVO N/A
  • IAS $51.30
  • Revenue Growth
  • EVO N/A
  • IAS 11.77
  • 52 Week Low
  • EVO $2.85
  • IAS $7.98
  • 52 Week High
  • EVO $8.39
  • IAS $17.53
  • Technical
  • Relative Strength Index (RSI)
  • EVO 42.87
  • IAS 43.77
  • Support Level
  • EVO $4.00
  • IAS $9.86
  • Resistance Level
  • EVO $4.63
  • IAS $10.15
  • Average True Range (ATR)
  • EVO 0.14
  • IAS 0.31
  • MACD
  • EVO -0.04
  • IAS -0.00
  • Stochastic Oscillator
  • EVO 16.88
  • IAS 34.82

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About IAS Integral Ad Science Holding Corp.

Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.

Share on Social Networks: